CELLINK X
LIVE

Serial Number

87736055

Owner

CELLINK Bioprinting AB

Attorney

Margarita Wallach,

Filing Date

Dec 27, 2017

Add to watchlist:

No watchlists yet
View on USPTO

CELLINK X Trademark

Serial Number: 87736055 • Registration: 6219220

CELLINK X is a trademark filed by CELLINK Bioprinting AB on December 27, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELLINK Bioprinting AB (23 trademarks)

LÃ¥ngfilsgatan 5

Entity Type: 98

CELLINK AB (30 trademarks)

ARVID WALLGRENS BACKE 20
GOTHENBURG 41346 , SE

Entity Type: 03

Trademark Details

Filing Date

December 27, 2017

Registration Date

December 15, 2020

Published for Opposition

May 19, 2020

Goods & Services

Biologically compatible polymers, namely, hydrogels used to manufacture polymeric networks used in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Media for cell culture for use in the biotechnological industry; Media for cell culture for use in non-medical research laboratories; Biological preparation for use in cell cultures other than for medical or veterinary use; Engineered biological tissues and tissue arrays, namely, human and animal organ, connective, epithelial, muscular, and nervous tissues and tissue arrays, for use in scientific and medical research; Biologically compatible materials, namely, hydrogels used to create polymeric networks used in the manufacture of living tissue; Proteins in raw material form for scientific and medical research

Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs; Preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implants of living tissues for guided tissue regeneration; Implants comprising living tissue; Implantable materials of living tissue for use in guided tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants of living tissues grown from stem cells; Transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Living tissues for transplant; Engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, connective, epithelial, muscular, and nervous tissue and organs, for medical purposes; Biological molecules to assist in the development of tissue; Haemostatic gel matrix preparations for treating wounds; Natural biomaterials for augmentation of bone, blood and tissue for medical purposes; Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; Pharmaceutical preparations for the treatment of bone diseases, for cartilaginous diseases, for vascular diseases, for neuronal degeneration, for degeneration of tendons and ligaments, for retinal degeneration, for renal degeneration, degeneration of soft tissue, for diseases with abnormal cell proliferation; Natural biomaterials for bone filling; Natural biomaterials for filling cartilage; Biological tissue cultures for medical use; Biological tissue cultures for medical purposes; Biological tissue grafts; Biological bone and skin tissues impregnated with lines of oxygen for tissue engineering applications to increase cell survival in tissue intended for subsequent implantation; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Implantable scaffolds comprising living tissue for maintaining tissue contour; Implants comprising living tissue; Natural biomaterials for augmentation of bone and tissue for medical purposes

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 15, 2025 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 15, 2023 ASGN
REGISTERED-PRINCIPAL REGISTER
Dec 15, 2020 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Nov 9, 2020 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 9, 2020 AITU
NOTICE OF ALLOWANCE CANCELLED
Oct 8, 2020 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Oct 8, 2020 D1BR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 27, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 27, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 27, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 27, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 27, 2020 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 14, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 19, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 19, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 16, 2020 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 14, 2020 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jul 8, 2019 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jul 8, 2019 GECD
ACTION CONTINUING FINAL - COMPLETED
Jul 8, 2019 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2019 CRFA
EX PARTE APPEAL-INSTITUTED
May 29, 2019 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 29, 2019 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 29, 2019 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 28, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 28, 2018 GNFN
FINAL REFUSAL E-MAILED
Nov 28, 2018 GNFR
FINAL REFUSAL WRITTEN
Nov 28, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 29, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 29, 2018 CRFA
ASSIGNED TO LIE
Oct 18, 2018 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 9, 2018 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 9, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 9, 2018 GNRN
NON-FINAL ACTION E-MAILED
Apr 9, 2018 GNRT
NON-FINAL ACTION WRITTEN
Apr 9, 2018 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 12, 2018 NWOS
NEW APPLICATION ENTERED
Dec 30, 2017 NWAP